Heart drug may help treat ALS, mouse study shows
Digoxin, a medication that has been used to treat heart
failure, may be adaptable for the treatment of amyotrophic lateral sclerosis
(ALS), a progressive, paralyzing disease, suggests new research at
the School of Medicine.
Scientists find new clues to brain’s wiring
New research provides an intriguing glimpse into the processes that establish connections between nerve cells in the brain. These connections, or synapses, allow nerve cells to transmit and process information involved in thinking and moving the body. Pictured is the study’s senior author, Azad Bonni, MD, PhD.
LeBlanc appointed new director of student health and wellness
Veteran physician Cheri LeBlanc, MD, has been treating patients during one of life’s most critical periods — the college years. As the new director of student health and wellness, LeBlanc hopes to educate students in ways that will last a lifetime.
Defects in brain cell migration linked to mental retardation
A rare, inherited form of mental retardation has led
scientists at the School of Medicine to
three important “travel agents” at work in the developing brain. The agents make it possible for brain neurons to travel
from where they are born to other brain regions where they will
permanently reside.